News
A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...
A new study reveals that the popular diabetes and weight-loss drug Ozempic might hold the key to relieving chronic migraines, ...
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
7d
Live Science on MSNDrug slashes migraine days by half in early trial — and it may work with completely 'new mechanism'The obesity drug liraglutide cut migraine days in half in a small trial, though more research is needed to exclude the ...
“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...
2d
ScienceAlert on MSNOzempic-Like Drugs Could Treat Chronic Migraines, Trial FindsMedications sold under brand names like Ozempic, Wegovy, and Saxenda have become famous for their weight-loss benefits, but ...
A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.
A small, early-stage study published in the journal Headache suggested a diabetes drug may ease migraines by lowering ...
Liraglutide, a medication commonly used to treat diabetes, has shown promising results in reducing chronic migraine in ...
A GLP-1 medication used to treat type 2 diabetes and obesity may help cut a person's monthly migraine days by about half, a ...
10d
News-Medical.Net on MSNTirzepatide rewires appetite and slashes calorie intake in new obesity trialA 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...
A recent study suggests that liraglutide, a drug similar to Ozempic, may reduce migraine frequency in obese individuals with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results